| UniProt ID | RPP29_HUMAN | |
|---|---|---|
| UniProt AC | O95707 | |
| Protein Name | Ribonuclease P protein subunit p29 | |
| Gene Name | POP4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 220 | |
| Subcellular Localization | Nucleus, nucleolus . | |
| Protein Description | Part of ribonuclease P, a protein complex that generates mature tRNA molecules by cleaving their 5'-ends. May function with RPP38 to coordinate the nucleolar targeting and/or assembly of RNase P.. | |
| Protein Sequence | MKSVIYHALSQKEANDSDVQPSGAQRAEAFVRAFLKRSTPRMSPQAREDQLQRKAVVLEYFTRHKRKEKKKKAKGLSARQRRELRLFDIKPEQQRYSLFLPLHELWKQYIRDLCSGLKPDTQPQMIQAKLLKADLHGAIISVTKSKCPSYVGITGILLQETKHIFKIITKEDRLKVIPKLNCVFTVETDGFISYIYGSKFQLRSSERSAKKFKAKGTIDL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MKSVIYHAL ------CCHHHHHHH | 54.13 | 25953088 | |
| 2 | Methylation | ------MKSVIYHAL ------CCHHHHHHH | 54.13 | 115975399 | |
| 3 | Phosphorylation | -----MKSVIYHALS -----CCHHHHHHHC | 16.67 | 28555341 | |
| 6 | Phosphorylation | --MKSVIYHALSQKE --CCHHHHHHHCHHH | 4.47 | 21945579 | |
| 10 | Phosphorylation | SVIYHALSQKEANDS HHHHHHHCHHHCCCC | 39.73 | 21945579 | |
| 12 | Acetylation | IYHALSQKEANDSDV HHHHHCHHHCCCCCC | 56.25 | 26051181 | |
| 12 | Ubiquitination | IYHALSQKEANDSDV HHHHHCHHHCCCCCC | 56.25 | 22817900 | |
| 17 | Phosphorylation | SQKEANDSDVQPSGA CHHHCCCCCCCCCHH | 39.22 | 25850435 | |
| 22 | Phosphorylation | NDSDVQPSGAQRAEA CCCCCCCCHHHHHHH | 29.66 | 29396449 | |
| 36 | "N6,N6-dimethyllysine" | AFVRAFLKRSTPRMS HHHHHHHHHCCCCCC | 37.54 | - | |
| 36 | Methylation | AFVRAFLKRSTPRMS HHHHHHHHHCCCCCC | 37.54 | 23644510 | |
| 38 | Phosphorylation | VRAFLKRSTPRMSPQ HHHHHHHCCCCCCHH | 40.97 | 26074081 | |
| 39 | Phosphorylation | RAFLKRSTPRMSPQA HHHHHHCCCCCCHHH | 20.96 | 26074081 | |
| 43 | Phosphorylation | KRSTPRMSPQAREDQ HHCCCCCCHHHCHHH | 18.36 | 30576142 | |
| 54 | Ubiquitination | REDQLQRKAVVLEYF CHHHHHHHHHHHHHH | 32.35 | 33845483 | |
| 60 | Phosphorylation | RKAVVLEYFTRHKRK HHHHHHHHHHHHHHH | 13.19 | 21214269 | |
| 62 | Phosphorylation | AVVLEYFTRHKRKEK HHHHHHHHHHHHHHH | 30.84 | - | |
| 70 | Ubiquitination | RHKRKEKKKKAKGLS HHHHHHHHHHHCCCC | 61.67 | 24816145 | |
| 90 | Ubiquitination | ELRLFDIKPEQQRYS HHHCCCCCHHHHHHH | 44.33 | 21906983 | |
| 118 | Acetylation | RDLCSGLKPDTQPQM HHHHCCCCCCCCCHH | 44.35 | 26051181 | |
| 118 | Ubiquitination | RDLCSGLKPDTQPQM HHHHCCCCCCCCCHH | 44.35 | - | |
| 129 | Ubiquitination | QPQMIQAKLLKADLH CCHHHHHHHHHCCCC | 37.67 | 29967540 | |
| 144 | Ubiquitination | GAIISVTKSKCPSYV CCEEEEECCCCCCCC | 45.84 | 33845483 | |
| 145 | Phosphorylation | AIISVTKSKCPSYVG CEEEEECCCCCCCCC | 30.08 | 17924679 | |
| 150 | Phosphorylation | TKSKCPSYVGITGIL ECCCCCCCCCCCEEH | 6.45 | 17924679 | |
| 161 | Phosphorylation | TGILLQETKHIFKII CEEHHHCHHHHHEEC | 18.24 | 17924679 | |
| 166 | Ubiquitination | QETKHIFKIITKEDR HCHHHHHEECCHHHH | 32.37 | 29967540 | |
| 215 | Ubiquitination | SAKKFKAKGTIDL-- HHHHHHCCCCCCC-- | 58.12 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 10 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RPP29_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPP29_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145; TYR-150 ANDTHR-161, AND MASS SPECTROMETRY. | |